H. R. 2498—33
‘‘(B) to provide appropriate referrals for the medical
treatment of men who have been screened under subpara-
graph (A) and to ensure, to the extent practicable, the
provision of appropriate followup services and support serv-
ices such as case management;
‘‘(C) to establish mechanisms through which State and
local health departments can monitor the quality of
screening procedures for prostate cancer, including the
interpretation of such procedures; and
‘‘(D) to improve, in consultation with the Health
Resources and Services Administration, the education,
training, and skills of health practitioners (including appro-
priate allied health professionals) in the detection and con-
trol of prostate cancer.
‘‘(8) To evaluate activities conducted under paragraphs (1)
through (7) through appropriate surveillance or program moni-
toring activities.’’; and
(2) in subsection (l)(1), by striking ‘‘1998’’ and inserting
‘‘2004’’.
(b) NATIONAL INSTITUTES OF HEALTH.—Section 417B(c) of the
Public Health Service Act (42 U.S.C. 286a–8(c)) is amended by
striking ‘‘and 1996’’ and inserting ‘‘through 2004’’.
TITLE VII—ORGAN PROCUREMENT AND
DONATION
SEC. 701. ORGAN PROCUREMENT ORGANIZATION CERTIFICATION.
(a) SHORT TITLE.—This section may be cited as the ‘‘Organ
Procurement Organization Certification Act of 2000’’.
(b) FINDINGS.—Congress makes the following findings:
(1) Organ procurement organizations play an important
role in the effort to increase organ donation in the United
States.
(2) The current process for the certification and recertifi-
cation of organ procurement organizations conducted by the
Department of Health and Human Services has created a level
of uncertainty that is interfering with the effectiveness of organ
procurement organizations in raising the level of organ dona-
tion.
(3) The General Accounting Office, the Institute of Medi-
cine, and the Harvard School of Public Health have identified
substantial limitations in the organ procurement organization
certification and recertification process and have recommended
changes in that process.
(4) The limitations in the recertification process include:
(A) An exclusive reliance on population-based measures
of performance that do not account for the potential in
the population for organ donation and do not permit consid-
eration of other outcome and process standards that would
more accurately reflect the relative capability and perform-
ance of each organ procurement organization.
(B) A lack of due process to appeal to the Secretary
of Health and Human Services for recertification on either
substantive or procedural grounds.
(5) The Secretary of Health and Human Services has the
authority under section 1138(b)(1)(A)(i) of the Social Security
H. R. 2498—34
Act (42 U.S.C. 1320b–8(b)(1)(A)(i)) to extend the period for
recertification of an organ procurement organization from 2
to 4 years on the basis of its past practices in order to avoid
the inappropriate disruption of the nation’s organ system.
(6) The Secretary of Health and Human Services can use
the extended period described in paragraph (5) for recertifi-
cation of all organ procurement organizations to—
(A) develop improved performance measures that
would reflect organ donor potential and interim outcomes,
and to test these measures to ensure that they accurately
measure performance differences among the organ procure-
ment organizations; and
(B) improve the overall certification process by incor-
porating process as well as outcome performance measures,
and developing equitable processes for appeals.
(c) CERTIFICATION AND RECERTIFICATION OF ORGAN PROCURE-
MENT
ORGANIZATIONS.—Section 371(b)(1) of the Public Health
Service Act (42 U.S.C. 273(b)(1)) is amended—
(1) by redesignating subparagraphs (D) through (G) as
subparagraphs (E) through (H), respectively;
(2) by realigning the margin of subparagraph (F) (as so
redesignated) so as to align with subparagraph (E) (as so
redesignated); and
(3) by inserting after subparagraph (C) the following:
‘‘(D) notwithstanding any other provision of law, has met
the other requirements of this section and has been certified
or recertified by the Secretary within the previous 4-year period
as meeting the performance standards to be a qualified organ
procurement organization through a process that either—
‘‘(i) granted certification or recertification within such
4-year period with such certification or recertification in
effect as of January 1, 2000, and remaining in effect
through the earlier of—
‘‘(I) January 1, 2002; or
‘‘(II) the completion of recertification under the
requirements of clause (ii); or
‘‘(ii) is defined through regulations that are promul-
gated by the Secretary by not later than January 1, 2002,
that—
‘‘(I) require recertifications of qualified organ
procurement organizations not more frequently than
once every 4 years;
‘‘(II) rely on outcome and process performance
measures that are based on empirical evidence,
obtained through reasonable efforts, of organ donor
potential and other related factors in each service area
of qualified organ procurement organizations;
‘‘(III) use multiple outcome measures as part of
the certification process; and
‘‘(IV) provide for a qualified organ procurement
organization to appeal a decertification to the Secretary
on substantive and procedural grounds;’’.
SEC. 702. DESIGNATION OF GIVE THANKS, GIVE LIFE DAY.
(a) FINDINGS.—Congress finds that—
H. R. 2498—35
(1) traditionally, Thanksgiving is a time for families to
take time out of their busy lives to come together and to
give thanks for the many blessings in their lives;
(2) approximately 21,000 men, women, and children in
the United States are given the gift of life each year through
transplantation surgery, made possible by the generosity of
organ and tissue donations;
(3) more than 66,000 Americans are awaiting their chance
to prolong their lives by finding a matching donor;
(4) nearly 5,000 of these patients each year (or 13 patients
each day) die while waiting for a donated heart, liver, kidney,
or other organ;
(5) nationwide there are up to 15,000 potential donors
annually, but families’ consent to donation is received for less
than 6,000;
(6) the need for organ donations greatly exceeds the supply
available;
(7) designation as an organ donor on a driver’s license
or voter’s registration is a valuable step, but does not ensure
donation when an occasion arises;
(8) the demand for transplantation will likely increase in
the coming years due to the growing safety of transplantation
surgery due to improvements in technology and drug develop-
ments, prolonged life expectancy, and increased prevalence of
diseases that may lead to organ damage and failure, including
hypertension, alcoholism, and hepatitis C infection;
(9) the need for a more diverse donor pool, including a
variety of racial and ethnic minorities, will continue to grow
in the coming years;
(10) the final decision on whether a potential donor can
share the gift of life usually is made by surviving family mem-
bers regardless of the patient’s initial intent;
(11) many Americans have indicated a willingness to donate
their organs and tissues but have not discussed this critical
matter with the family members who are most likely to make
the decision, if the occasion arises, as to whether that person
will be an organ and tissue donor;
(12) some family members may be reluctant to give consent
to donate their deceased loved one’s organs and tissues at
a very difficult and emotional time if that person has not
clearly expressed a desire or willingness to do so;
(13) the vast majority of Americans are likely to spend
part of Thanksgiving Day with some of those family members
who would be approached to make such a decision; and
(14) it is fitting for families to spend a portion of that
day discussing how they might give life to others on a day
devoted to giving thanks for their own blessings.
(b) DESIGNATION.—November 23, 2000, Thanksgiving Day, is
hereby designated as a day to ‘‘Give Thanks, Give Life’’ and to
discuss organ and tissue donation with other family members so
that informed decisions can be made if the occasion to donate
arises.
H. R. 2498—36
TITLE VIII—ALZHEIMER’S CLINICAL
RESEARCH AND TRAINING
SEC. 801. ALZHEIMER’S CLINICAL RESEARCH AND TRAINING AWARDS.
Subpart 5 of part C of title IV of the Public Health Service
Act (42 U.S.C. 285e et seq.) is amended—
(1) by redesignating section 445I as section 445J; and
(2) by inserting after section 445H the following:
‘‘SEC. 
445I. 
ALZHEIMER’S 
CLINICAL 
RESEARCH 
AND 
TRAINING
AWARDS.
‘‘(a) IN GENERAL.—The Director of the Institute is authorized
to establish and maintain a program to enhance and promote the
translation of new scientific knowledge into clinical practice related
to the diagnosis, care and treatment of individuals with Alzheimer’s
disease.
‘‘(b) SUPPORT
OF PROMISING CLINICIANS.—In order to foster
the application of the most current developments in the etiology,
pathogenesis, diagnosis, prevention and treatment of Alzheimer’s
disease, amounts made available under this section shall be directed
to the support of promising clinicians through awards for research,
study, and practice at centers of excellence in Alzheimer’s disease
research and treatment.
‘‘(c) EXCELLENCE IN CERTAIN FIELDS.—Research shall be carried
out under awards made under subsection (b) in environments of
demonstrated excellence in neuroscience, neurobiology, geriatric
medicine, and psychiatry and shall foster innovation and integration
of such disciplines or other environments determined suitable by
the Director of the Institute.
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the purpose of
carrying out this section, there are authorized to be appropriated
$2,250,000 for fiscal year 2001, and such sums as may be necessary
for each of fiscal years 2002 through 2005.’’.
TITLE 
IX—SEXUALLY 
TRANSMITTED
DISEASE CLINICAL RESEARCH AND
TRAINING
SEC. 901. SEXUALLY TRANSMITTED DISEASE CLINICAL RESEARCH AND
TRAINING AWARDS.
Subpart 6 of part C of title IV of the Public Health Service
Act (42 U.S.C. 285f et seq.) is amended by adding at the end
the following:
‘‘SEC. 447B. SEXUALLY TRANSMITTED DISEASE CLINICAL RESEARCH
AND TRAINING AWARDS.
‘‘(a) IN GENERAL.—The Director of the Institute is authorized
to establish and maintain a program to enhance and promote the
translation of new scientific knowledge into clinical practice related
to the diagnosis, care and treatment of individuals with sexually
transmitted diseases.
‘‘(b) SUPPORT
OF PROMISING CLINICIANS.—In order to foster
the application of the most current developments in the etiology,
H. R. 2498—37
pathogenesis, diagnosis, prevention and treatment of sexually trans-
mitted diseases, amounts made available under this section shall
be directed to the support of promising clinicians through awards
for research, study, and practice at centers of excellence in sexually
transmitted disease research and treatment.
‘‘(c) EXCELLENCE IN CERTAIN FIELDS.—Research shall be carried
out under awards made under subsection (b) in environments of
demonstrated excellence in the etiology and pathogenesis of sexually
transmitted diseases and shall foster innovation and integration
of such disciplines or other environments determined suitable by
the Director of the Institute.
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the purpose of
carrying out this section, there are authorized to be appropriated
$2,250,000 for fiscal year 2001, and such sums as may be necessary
for each of fiscal years 2002 through 2005.’’.
TITLE X—MISCELLANEOUS PROVISION
SEC. 1001. TECHNICAL CORRECTION TO THE CHILDREN’S HEALTH ACT
OF 2000.
(a) IN GENERAL.—Section 2701 of the Children’s Health Act
of 2000 is amended by striking ‘‘part 45 of title 46’’ and inserting
‘‘part 46 of title 45’’.
(b) EFFECTIVE DATE.—The amendment made by subsection (a)
takes effect on the date of the enactment of the Children’s Health
Act of 2000.
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.